Pharmaceuticals in Singapore
Summary
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Singaporean pharmaceuticals market had total revenues of $940.6m in 2019, representing a compound annual growth rate (CAGR) of 2% between 2015 and 2019.
- The Singaporean healthcare is the best in the world in terms of both efficiency and health outcome results. Singapore has a record of providing a world-class business environment and skilled talent pool to companies.
- The Singapore government has invested aggressively in its biomedical industry over the last few years.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
- What was the size of the Singapore pharmaceuticals market by value in 2019?
- What will be the size of the Singapore pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Singapore's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market share
- 1.5. Market rivalry
- 1.6. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Market share
- 7.2. Who are the leading players?
- 7.3. What are the strengths/weaknesses of leading players?
- 7.4. What strategies do leading players follow?
- 7.5. What trends have impacted the market?
- 7.6. Are there any threats towards leading players?
- 8 Company Profiles
- 8.1. Novartis AG
- 8.2. Pfizer Inc.
- 8.3. Astellas Pharma Inc.
- 8.4. GlaxoSmithKline Plc
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Singapore pharmaceuticals market value: $ billion, 2015-19
- Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2019
- Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
- Table 4: Singapore pharmaceuticals market share: % share, by value, 2019
- Table 5: Novartis AG: key facts
- Table 6: Novartis AG: Annual Financial Ratios
- Table 7: Novartis AG: Annual Financial Ratios (Continued)
- Table 8: Novartis AG: Key Employees
- Table 9: Novartis AG: Key Employees Continued
- Table 10: Pfizer Inc.: key facts
- Table 11: Pfizer Inc.: Annual Financial Ratios
- Table 12: Pfizer Inc.: Key Employees
- Table 13: Pfizer Inc.: Key Employees Continued
- Table 14: Astellas Pharma Inc.: key facts
- Table 15: Astellas Pharma Inc.: Annual Financial Ratios
- Table 16: Astellas Pharma Inc.: Key Employees
- Table 17: Astellas Pharma Inc.: Key Employees Continued
- Table 18: GlaxoSmithKline Plc: key facts
- Table 19: GlaxoSmithKline Plc: Annual Financial Ratios
- Table 20: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
- Table 21: GlaxoSmithKline Plc: Key Employees
- Table 22: GlaxoSmithKline Plc: Key Employees Continued
- Table 23: Singapore size of population (million), 2015-19
- Table 24: Singapore gdp (constant 2005 prices, $ billion), 2015-19
- Table 25: Singapore gdp (current prices, $ billion), 2015-19
- Table 26: Singapore inflation, 2015-19
- Table 27: Singapore consumer price index (absolute), 2015-19
- Table 28: Singapore exchange rate, 2015-19
- List of Figures
- Figure 1: Singapore pharmaceuticals market value: $ billion, 2015-19
- Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2019
- Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
- Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2019
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2019
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2019
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2019
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2019
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2019
- Figure 10: Singapore pharmaceuticals market share: % share, by value, 2019
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook